Bioavailability of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg single dose vs. single components

Minerva Med. 2019 Jun;110(3):264-267. doi: 10.23736/S0026-4806.18.05854-8. Epub 2018 Nov 27.

Authors

Roberto Imberti¹, Simona De Gregori², Leonardo Rabaglia³, Mario Regazzi⁴

Affiliations

¹ Phase I Clinical Trial and Experimental Therapy Unit, IRCCS Policlinic San Matteo Foundation, Pavia, Italy - [email protected].
² Unit of Clinical and Experimental Pharmacokinetics, IRCCS Policlinic San Matteo Foundation, Pavia, Italy.
³ Mediolanum farmaceutici S.p.A., Milan, Italy.
⁴ Società Italiana di Farmacocinetica e Biofarmaceutica (S.I.F.E.B.), Pavia, Italy.

PMID: 30484591
DOI: 10.23736/S0026-4806.18.05854-8

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adult
Biological Availability
Colchicine / administration & dosage
Colchicine / analogs & derivatives*
Colchicine / pharmacokinetics
Cross-Over Studies
Diclofenac / administration & dosage*
Diclofenac / pharmacokinetics*
Drug Therapy, Combination
Female
Humans
Injections, Intramuscular
Male

Substances

Diclofenac
Colchicine
thiocolchicoside